A U.S. federally funded systematic evidence review of 3,000 studies (25 of which had scientifically valid evidence) found that just three products showed evidence providing pain relief.
A new study published in the Canadian Medical Association Journal found that after medication policy measures were introduced at the beginning of the pandemic, the number of drug shortages dropped.
Amylyx Pharmaceuticals said in a press release Monday that Canada is the first country in the world to give the regulatory greenlight for Albrioza as a treatment for the devastating neurodegenerative disease.
